0001144204-18-037217.txt : 20180703
0001144204-18-037217.hdr.sgml : 20180703
20180703160040
ACCESSION NUMBER: 0001144204-18-037217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180702
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RINGO WILLIAM R
CENTRAL INDEX KEY: 0001238325
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35005
FILM NUMBER: 18937024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001426800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
BUSINESS PHONE: (212) 554-4388
MAIL ADDRESS:
STREET 1: 11711 N. MERIDIAN STREET
STREET 2: SUITE 310
CITY: CARMEL
STATE: IN
ZIP: 46032
FORMER COMPANY:
FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC
DATE OF NAME CHANGE: 20080211
4
1
v497988_4.xml
OWNERSHIP DOCUMENT
X0306
4
2018-07-02
0
0001426800
ASSEMBLY BIOSCIENCES, INC.
ASMB
0001238325
RINGO WILLIAM R
C/O ASSEMBLY BIOSCIENCES, INC.
11711 N. MERIDIAN STREET, SUITE 310
CARMEL
IN
46032
1
0
0
0
Common Stock
2018-07-02
4
M
0
1000
7.20
A
20465
D
Common Stock
2018-07-02
4
S
0
1000
38.503
D
19465
D
Stock Option (right to buy)
7.20
2018-07-02
4
M
0
1000
0
D
2024-07-10
Common Stock
1000
49000
D
The option exercise and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.515, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within.
This option, initially representing a right to purchase 64,000 shares, became exercisable in three equal installments on July 11, 2014; July 11, 2015; and July 11, 2016.
/s/ Elizabeth H. Lacy, as Attorney-in-Fact
2018-07-03